Report cover image

Exome Sequencing Market

Published Nov 25, 2019
Length 31 Pages
SKU # KLI16103183

Description

Exome Sequencing Market The increasing popularity of next-generation systems has fueled systems and sequencers, but the cost of sequencing – despite price declines – has led to demands for more efficient methods. Exome Sequencing is a widely used NGS technique that sequences all the exons in a genome. Rather than sequencing the entire human genome, only pieces of an individual's DNA that provide instructions for making proteins are sequenced. These pieces, called exons, are thought to make up roughly 2 percent of a person's genome. Because most known mutations that cause disease occur in exons, whole exome sequencing is thought to be an efficient method to identify possible disease-causing mutations. Exome Sequencing Market provides the following data:
  • Exome Sequencing Market, 2019-2024
  • Exome Sequencing Market by Region, 2019 (%; US, Europe, ROW)

Table of Contents

31 Pages
    • Demand for Effectiveness
    • Selected Products on the Market
    • Challenges, Possible Disruption in the Market
    • WGS/WES Comparison
    • Size and Growth of the Market
    • Exome Sequencing Recent Developments
    • Products on the Market
    • Application Forecast of Exome Sequencing: End Users
    • Size and Growth of the Market
    • 10X Genomics
    • Agilent Technologies
    • BGI Genomics (formerly Beijing Genome Institute)
    • Illumina
    • Oxford Nanopore
    • Qiagen N.V.
    • Roche Diagnostics
    • Thermo Fisher Scientific Inc.
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.